PLAY PODCASTS
Adverse Events Associated with BTK Inhibitor Treatment
Episode 74

Adverse Events Associated with BTK Inhibitor Treatment

Listen to Amy Goodrich, RN, MSN, CRNP-AC, provide a nursing-focused overview of managing some of the more common adverse events associated with BTK inhibitors.

Decera Clinical Education Oncology Podcast · Amy Goodrich RN MSN CRNP-AC

July 23, 202112m 30s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this podcast episode, Amy Goodrich, CRNP, discusses nursing perspectives on managing adverse events associated with BTK inhibitor therapy. Topics in this podcast include:

  • BTK inhibitor selectivity
  • BTK inhibitor adverse event profiles
  • Ibrutinib intolerance
  • Management of common adverse events

Presenter:

Amy Goodrich, RN, MSN, CRNP-AC
Research Associate/Nurse Practitioner
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Baltimore, Maryland

CE/AAPA credit available by visiting the online program:
https://bit.ly/3zMXFOp

Link to full program, including downloadable slidesets:
https://bit.ly/3iwN9Ub


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

arthralgiasmantle cell lymphomab-cell receptoribrutinibwaldenström macroglobulinemiableedingzanubrutiniblymphomasmusculoskeletalresonate trialcllbtkace-cl-001acalabrutinibinfectionsbtkiheadaches